This report from Life Science Intelligence provides the latest market data for the Global Percutaneous Atherectomy Devices Market. Information covered by this report includes:
The global market for percutaneous atherectomy devices is expected to reach an estimated $543.9 million in 2020 and projected to increase at a CAGR (2020-2024) of 9.6%.
This report covers the impact of COVID-19 on the percutaneous atherectomy devices market, including a recent forecast from 2020 to 2024. COVID-19 has also impacted leading competitors, such as Cardiovascular Systems, Boston Scientific, Medtronic, and others. The report provides insights into trends, drivers, and limiters of the percutaneous atherectomy devices market, as well as highlights potential opportunities.
The percutaneous atherectomy market was severely impacted by the COVID-19 pandemic as a result of the postponement of non-critical interventional cardiology procedures. While the decline in interventional cardiology procedures in 2020 was substantial, procedure volumes are projected to return to pre-COVID-19 levels in 2021.
Cardiovascular Systems, Boston Scientific, and Medtronic dominate the market with more than 90% of the market share for the global percutanoues artherectomy devices market. The leading product platforms in the market include Cardiovascular Systems’ Diamondback, Boston Scientific’s Rotablator and Jetstream, and Philips’ Phoenix system.